[Immunotherapy for non-small-cell lung cancer]. 2021

Maxime Frelaut, and Benjamin Besse
Département de médecine oncologique, institut Gustave-Roussy, Villejuif, France.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Maxime Frelaut, and Benjamin Besse
September 2014, Tuberculosis and respiratory diseases,
Maxime Frelaut, and Benjamin Besse
March 2024, Respiratory investigation,
Maxime Frelaut, and Benjamin Besse
August 2014, Expert opinion on biological therapy,
Maxime Frelaut, and Benjamin Besse
September 2019, JAAPA : official journal of the American Academy of Physician Assistants,
Maxime Frelaut, and Benjamin Besse
October 2012, Cancer treatment reviews,
Maxime Frelaut, and Benjamin Besse
November 2023, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Maxime Frelaut, and Benjamin Besse
January 2009, Methods in molecular biology (Clifton, N.J.),
Maxime Frelaut, and Benjamin Besse
May 2014, World journal of clinical oncology,
Maxime Frelaut, and Benjamin Besse
July 2022, Innere Medizin (Heidelberg, Germany),
Maxime Frelaut, and Benjamin Besse
December 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Copied contents to your clipboard!